Stock analysts at Zacks Small Cap raised their Q1 2025 earnings estimates for shares of Evaxion Biotech A/S in a research report issued to clients and investors on Thursday, February 6th. Zacks Small ...

The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.

Analysts at Roth Capital issued their FY2028 earnings per share (EPS) estimates for shares of Sensus Healthcare in a research note issued to investors on Thursday, February 6th. Roth Capital analyst J ...